Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations Meeting Abstract


Authors: Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
Abstract Title: Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602499
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.8018
Notes: Meeting Abstract: 8018-- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    281 Yu
  2. Marc Ladanyi
    1326 Ladanyi
  3. Gregory J Riely
    599 Riely
  4. Maria Eugenia Arcila
    657 Arcila
  5. Mark Kris
    869 Kris
  6. Matthew David Hellmann
    411 Hellmann